NCT06642493 (EFFP-TDP) is a NA clinical trial of Fresh frozen plasma in Dengue Fever, sponsored by Sheikh Hasina National Institute of Burn and Plastic Surgery.

Who is sponsoring NCT06642493?

NCT06642493 is sponsored by Sheikh Hasina National Institute of Burn and Plastic Surgery.

What drugs are being tested in NCT06642493?

Interventions in NCT06642493: Fresh frozen plasma.

What condition does NCT06642493 study?

NCT06642493 studies Dengue Fever, Dengue Hemorrhagic Fever, Dengue Shock Syndrome.

Is NCT06642493 still recruiting?

NCT06642493 is currently active, enrolled. Last updated 15 October 2024.

Last reviewed 2024-10-15 · How we verify

NCT06642493: EFFP-TDP

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Efficacy of Fresh Frozen Plasma (FFP) in Treating Thrombocytopenia in Dengue Patients

Active, enrolled NA Last updated 15 October 2024

What this trial tests

NA trial testing Fresh frozen plasma in Dengue Fever in 300 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline

1 May 2024

Primary endpoint
31 December 2024

31 December 2024

Quick facts

Lead sponsor	Sheikh Hasina National Institute of Burn and Plastic Surgery
Phase	NA
Status	Active, enrolled
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	health services research
Enrollment	300
Start date	1 May 2024
Primary completion	31 December 2024
Estimated completion	31 December 2024
Sites	1 location across Bangladesh

Drugs / interventions tested

Fresh frozen plasma — full drug profile →

Conditions studied

Dengue Fever — all drugs for Dengue Fever →
Dengue Hemorrhagic Fever — all drugs for Dengue Hemorrhagic Fever →
Dengue Shock Syndrome — all drugs for Dengue Shock Syndrome →

Sponsor

Sheikh Hasina National Institute of Burn and Plastic Surgery

Who can join

Adults 18 to 65, any sex, with Dengue Fever or Dengue Hemorrhagic Fever. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This clinical trial seeks to assess the effectiveness of fresh frozen plasma (FFP) in the treatment of thrombocytopenia in individuals with dengue. Dengue is a viral infection marked by thrombocytopenia, potentially resulting in significant hemorrhagic consequences. FFP is frequently utilized in the management of coagulopathies, and this study will investigate its efficacy in enhancing platelet count and mitigating bleeding risks in dengue patients with thrombocytopenia. The research will be executed as a randomized, controlled trial to evaluate outcomes in patients receiving routine care with and without FFP transfusion.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Fresh frozen plasma

Trials testing the same drug.

NCT04683614 — Intraoperative Norepinephrine Versus Fresh Frozen Plasma in Patients Undergoing HIPEC to Reduce Renal Insult · NA · completed
NCT03598907 — Point-of-care Management of Coagulopathy in Lung Transplantation · terminated

Other recruiting trials for Dengue Fever

Currently open trials in the same condition.

NCT06579755 — A Study of Dengue Tetravalent Vaccine (TDV) in Adults (Age 45 to 60 and >60 to 79 Years) · Phase 3 · recruiting
NCT07409857 — International Registry of Dengue Infection in Congenital Bleeding Disorders (DengueCBDR) · recruiting
NCT07047521 — A Study on a New Tetravalent Dengue Vaccine (TDV) Formulation in Healthy Adults · Phase 3 · active not recruiting
NCT07007585 — Risk Factors for Hospitalization and Transfusion Criteria in Patients With Dengue Virus Infection · recruiting
NCT06665035 — A Study of 2 Doses of Tetravalent Dengue Vaccine (TDV) in Infants and Toddlers · Phase 3 · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06642493 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Sheikh Hasina National Institute of Burn and Plastic Surgery
Last refreshed: 15 October 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06642493.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing